Mitigation of caffeine-induced fetopathy in mice by pretreatment with beta-adrenergic blocking agents.
In a previous experiment, fetopathic effects of caffeine were significantly reduced by pretreatment with propranolol at dosage levels of 2.5 to 10 mg/kg. The present experiments were undertaeken to investigate the relation between time intervals of propranolol pretreatment and its effect on reducing fetopathy. Furthermore, the effect of timolol, another beta-adrenergic blocking agent, on reducing fetopathy was compared with that of propranolol. Propranolol (5 mg/kg) administered 15, 30 or 60 minutes before caffeine treatment significantly reduced the caffeine-induced fetopathy. The optimal effect was found when propranolol was given 30 minutes before caffine. The reduction in fetopathy by timolol pretreatment was comparable to that of propranolol. The results lend support to the hypothesis that the fetopathic effect of caffeine is linked with released catecholamines in material or fetal issues of mice.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000818:Animals; D002110:Caffeine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000187:drug effects*; D051379:Mice; D008813:Mice, Inbred ICR; D011247:Pregnancy; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors; D013999:Timolol / Q000494:pharmacology* / Q000627:therapeutic use
D011412:Propanolamines; D002110:Caffeine; D013999:Timolol; D011433:Propranolol